Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Non-cash Items: 2014-2016

Historic Non-cash Items for Viridian Therapeutics, Inc.\DE (VRDN) over the last 3 years, with Dec 2016 value amounting to $37,465.

  • Viridian Therapeutics, Inc.\DE's Non-cash Items fell 51.97% to $37,465 in Q4 2016 from the same period last year, while for Dec 2016 it was $37,465, marking a year-over-year decrease of 51.97%. This contributed to the annual value of $37,465 for FY2016, which is 51.97% down from last year.
  • According to the latest figures from FY2016, Viridian Therapeutics, Inc.\DE's Non-cash Items is $37,465, which was down 51.97% from $78,009 recorded in FY2015.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Non-cash Items peaked at $392,000 during FY2014, and registered a low of $37,465 during FY2016.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Non-cash Items averaged around $169,158, with its median value being $78,009 (2015).
  • Data for Viridian Therapeutics, Inc.\DE's Non-cash Items shows a maximum YoY tumbled of 80.10% (in 2015) over the last 5 years.
  • Over the past 3 years, Viridian Therapeutics, Inc.\DE's Non-cash Items (Yearly) stood at $392,000 in 2014, then tumbled by 80.10% to $78,009 in 2015, then crashed by 51.97% to $37,465 in 2016.